The Indian biotechnology sector continues to grow each year. While the majority of the industry is focused in the biopharmaceutical space, India is home to several large agri-biotechnology companies.
- India produces the majority of the global supply of the measles vaccine.
- By the end of 2016, India had over 1,000 biotech startups and this number continues to grow.
Association of Biotech-Led Enterprises (ABLE)
Association of Biotechnology Led Enterprises – ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector.
ABLE has over 400 members from all across India representing all verticals of the sector like Agribiotech, Bio-pharma, Industrial biotech, Bioinformatics, Investment banks and Venture Capital firms, leading Research and Academic Institutes and Law Firms and Equipment Suppliers.
The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector.
ABLE thus catalyses a symbiotic interface between the industry, the government, academic and research institutes and domestic and international investors.